Survival Is Poorer in Patients With Secondary Core Binding Factor Acute Myelogenous Leukemia Compared With De Novo Core Binding Factor Leukemia.
Blood - United States
doi 10.1182/blood.v110.11.2856.2856
Full Text
Open PDFAbstract
Available in full text
Date
November 16, 2007
Authors
Publisher
American Society of Hematology